OLTA Stellar Yield 6
Calibrated launch value from the rulebook. This basket carries no order panel today.
Why this basket exists
What the construction is trying to capture, who it is built for, and how it is meant to be sized inside a wider allocation.
Yield on Stellar dollars · a basket of yield-bearing dollar instruments issued on Stellar (Ondo USDY, Spiko US and EU T-bill funds, Figure YLDS, MoneyGram MGUSD) with a thin yield-wrapped XLM sleeve. The cash-plus lane, distinct from the RWA-growth thesis. Honesty · YLDS is a registered security with eligibility limits, MGUSD is new in 2026, and the legs price at issuer-attested NAV, not open-market discovery. Under study while the Stellar settlement rail is designed.
- Stellar family · Conservative risk tier
- Rule-based, divisor-method NAV
No committee note is published for this basket yet. The text above is its catalogue description; the framing beside it is derived from the mandate and the risk tier.
6 holdings, drawn to scale
Each tile's area is its weight in the basket, so the picture and the table below it are the same data read two ways.
| Holding | Share | Weight | |
|---|---|---|---|
| 01USDY | 30% | ||
| 02USTBL | 20% | ||
| 03YLDS | 20% | ||
| 04EUTBL | 15% | ||
| 05MGUSD | 10% | ||
| 06YXLM | 5% | ||
| Total | 100% |
Why each name earned its seat
Research notes per constituent: the case for the asset, the regime that suits it, and the risk the seat carries.
- USDY30%Growth
Research note pending for this holding. Its weight and its role in the mandate are published above.
- USTBL20%Growth
Research note pending for this holding. Its weight and its role in the mandate are published above.
- YLDS20%Growth
Research note pending for this holding. Its weight and its role in the mandate are published above.
- EUTBL15%Growth
Research note pending for this holding. Its weight and its role in the mandate are published above.
- MGUSD10%Growth
Research note pending for this holding. Its weight and its role in the mandate are published above.
- YXLM5%Growth
Research note pending for this holding. Its weight and its role in the mandate are published above.
What the numbers say
Simulated on historical constituent prices. A Sharpe is only published once the measured window clears 90 days, and drawdowns keep their sign.
No backtest is on record for this basket. The methodology asks for at least 90 days of usable constituent history before a record is published, and this composition does not clear it yet.
What could go wrong
Priced off this basket's own weights rather than off a generic disclaimer, so every figure below can be checked against the table above.
Drawdowns are bounded relative to the broader crypto market. Constituent caps and liquidity filters contain concentration risk. Full risk parameters live in the methodology rulebook.
- Top-name weightLow
USDY is the largest position at 30%. Capped by methodology but still drives index direction.
- Pre-live statusLow
Preview index. NAV is computed but the basket isn't yet open for live allocation.
| Scenario | Loss on net asset value |
|---|---|
| USDY loses half its valueLargest holding, 30.0% of the basket | −15.0%Mechanical |
| The three largest holdings fall 30%USDY, USTBL, YLDS · 70.0% of the basket together | −21.0%Mechanical |
The mechanical rows hold every other holding still, which is the optimistic case. In practice these holdings tend to move together rather than one at a time. Read the figures as a floor on the damage, never a ceiling.
The research behind the construction
Worth a second look later
OSTY6 is under methodology review, so it carries no buy action today. The weights and the cadence are still being settled, and publishing an order panel over rules that are about to change would be the wrong kind of confidence. Everything above stays on the page while the work runs: the composition, the measured record and the risk flags all move with the research.